- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: TNFRSF6B
Gene name: tumor necrosis factor receptor superfamily, member 6b, decoy
HGNC ID: 11921
Synonyms: DcR3, DCR3, TR6, M68
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | BAX | 1 hits |
| 2 | BCL2 | 1 hits |
| 3 | FAS | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 25458316 | FAS/FASL-mediated cell death in the bovine endometrium. |
| 2 | 25458316 | We examined (1) the cyclic expressions of apoptosis-related factors, FAS, DcR3, BCL2 and BAX, in the bovine endometrium and (2) the effect of death ligands on the viability of, and FAS mRNA expression in, cultured bovine endometrial epithelial and stromal cells. |
| 3 | 25458316 | FAS expression did not change during the estrous cycle, whereas DcR3 expression was higher at the mid and late luteal stages than at the early luteal and follicular stages. |
| 4 | 25458316 | BCL2 expression was higher at the late luteal stage than at the early luteal and follicular stages, and the BAX/BCL2 ratio was higher at the early luteal stage than at the late luteal stage. |
| 5 | 25458316 | Treatment or pretreatment with tumor necrosis factor-α (TNF)+interferon γ (IFNG) in combination with FAS ligand significantly reduced the viability of both epithelial and stromal cells. |
| 6 | 25458316 | Furthermore, TNF+IFNG treatment significantly increased the expression of FAS mRNA in both types of endometrial cells. |
| 7 | 25458316 | FAS/FASL-mediated cell death in the bovine endometrium. |
| 8 | 25458316 | We examined (1) the cyclic expressions of apoptosis-related factors, FAS, DcR3, BCL2 and BAX, in the bovine endometrium and (2) the effect of death ligands on the viability of, and FAS mRNA expression in, cultured bovine endometrial epithelial and stromal cells. |
| 9 | 25458316 | FAS expression did not change during the estrous cycle, whereas DcR3 expression was higher at the mid and late luteal stages than at the early luteal and follicular stages. |
| 10 | 25458316 | BCL2 expression was higher at the late luteal stage than at the early luteal and follicular stages, and the BAX/BCL2 ratio was higher at the early luteal stage than at the late luteal stage. |
| 11 | 25458316 | Treatment or pretreatment with tumor necrosis factor-α (TNF)+interferon γ (IFNG) in combination with FAS ligand significantly reduced the viability of both epithelial and stromal cells. |
| 12 | 25458316 | Furthermore, TNF+IFNG treatment significantly increased the expression of FAS mRNA in both types of endometrial cells. |